AGEN
NASDAQ · Biotechnology
Agenus Inc
$9.43
+0.89 (+10.42%)
AGEN News3 articles
Agenus Closes at $5.01, Slightly Below $170M Warrant Trigger
Agenus closed at $5.01, two cents under its Series B warrant price of $5.03, which could bring $170M. The stock surged 49.6% last week, but full warrant exercise could nearly triple share count.
Agenus Shares Surge 83% on $340M Financing for Key Colon Cancer Trial
Agenus shares surged 83% on news of up to $340M financing for a pivotal colon cancer trial, but three-quarters of that amount hinges on investor warrants.
Agenus Stock Surges 59% on $340 Million Funding Deal
Agenus (AGEN) shares jumped 59% premarket on a $340 million financing deal, though full exercise of warrants could nearly triple the share count. The funds support a strategic pivot to a major colon cancer trial.